4.8 Article

Milvexian for the Prevention of Venous Thromboembolism

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

Factor XI Inhibition to Uncouple Thrombosis From Hemostasis JACC Review Topic of the Week

Charles Hsu et al.

Summary: Hemostasis and thrombosis are closely linked, with factor XI inhibitors potentially providing a safer alternative to current anticoagulants. Clinical studies are ongoing to determine the efficacy of factor XI inhibitors in attenuating thrombosis without disrupting hemostasis.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Article Medicine, General & Internal

Abelacimab for Prevention of Venous Thromboembolism

Peter Verhamme et al.

Summary: Factor XI plays a significant role in the development of postoperative venous thromboembolism. Inhibition of Factor XI with a single intravenous dose of abelacimab after total knee arthroplasty was effective in preventing venous thromboembolism and had a low risk of bleeding.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty The FOXTROT Randomized Clinical Trial

Jeffrey I. Weitz et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

Harry R. Bueller et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Mathematical & Computational Biology

Model-based dose finding under model uncertainty using general parametric models

Jose Pinheiro et al.

STATISTICS IN MEDICINE (2014)

Article Hematology

Congenital Factor XI Deficiency: An Update

Stefano Duga et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)

Article Hematology

Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis

Ophira Salomon et al.

THROMBOSIS AND HAEMOSTASIS (2011)